The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.
Published: 08 Aug 2025
Citation: Akdeniz N, Ebinç S, Barışta İ, et al. Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas. J Curr Hematol Oncol Res. 2025;3(3):49-56.
Published: 08 Aug 2025
Citation: Balık B, Akdeniz A, Koyuncu MB, et al. Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center. J Curr Hematol Oncol Res. 2025;3(3):57-61.
Published: 08 Aug 2025
Citation: Kahraman S, Doğan A, Çelik S, Esen R, Yıldırım Doğan N. Prognostic factors in diffuse large B cell lymphoma: a retrospective analysis from a tertiary center. J Curr Hematol Oncol Res. 2025;3(3):62-66.
Published: 08 Aug 2025
Citation: Yanardağ Açık D, Karabulut ZT. The role of ELABELA in targeted treatment of acute myeloid leukemia. J Curr Hematol Oncol Res. 2025;3(3):67-73.
Published: 08 Aug 2025
Citation: Gülsar Çaycı MG, Satılmış O, Demircioğlu S, Tekinalp A. A rare case report: cytarabine-induced skin rash. J Curr Hematol Oncol Res. 2025;3(3):74-76.
Published: 30 Aug 2023
Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.
Published: 26 Feb 2023
Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4
Published: 30 Aug 2023
Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.